Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test

Completed

Conditions studied: Covid19

In brief

The INDICAID™ Rapid Antigen Test was used in real-world outbreak testing. The antigen test was used together with PCR testing. This study was designed to evaluate whether the addition of a rapid antigen test decreased time to results in a real-world setting.

Key facts

Study ID

NCT04904510

Run by

University of California, Los Angeles

People needed

297

Starts

2020-11-20

Expected to finish

2021-03-09

Last updated by the study team

2023-02-15

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• at least 5 years of age and report onset
• at least two of the following COVID-19 symptoms within 5 days or less: fever or chills, fatigue, sore throat, congestion or runny nose, cough, headache, diarrhea, shortness of breath or difficulty breathing, muscle or body aches, new loss of taste or smell, nausea, or vomiting.

You may not qualify if…

• That do not fit inclusion criteria or vulnerable populations

Where it is running

• CityHealth Urgent Care Oakland — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.